Inflammation and Type 2 Diabetes: Results from KORA Augsburg
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes is associated with a systemic low-grade inflammation. First data provided by cross-sectional studies from as early as the 1960s demonstrated elevated systemic levels of glycoproteins and acute-phase reactants and increased leukocyte counts in type 2 diabetes patients. Subsequently, prospective studies showed that elevated concentrations of several acute-phase proteins and cytokines are predictive of later type 2 diabetes. Immune gene variants in man and in animal models were found to affect insulin resistance and diabetes incidence. Antidiabetic treatment by medication, diet or physical activity results in a significant decrease of systemic immune mediator concentrations. Immunological analyses of the KORA Survey S4 (1999/2001) allowed us to show that levels of circulating acute-phase proteins like CRP and of IL-6 are highly correlated and associated not only with overt type 2 diabetes, but already with impaired glucose tolerance (IGT) pointing out a role of these mediators in the pathogenesis of type 2 diabetes. On the contrary, TNFalpha was neither coregulated with CRP nor associated with diabetes status. Our study therefore shows that type 2 diabetes is accompanied by a non-random and differential upregulation of components of the innate immunity and suggests that this inflammatory condition is involved in the aetiology of the disease. Future work will extend the range of analysed immune mediators to chemokines and will also investigate the association of immune markers with indices of obesity to elucidate the relevance of this traditional risk factor for low-grade inflammation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated circulating concentrations of inflammatory biomarkers are consistently found in people with T2DM. 5,6”
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Recent studies indicated that obesity is associated with an increasing infiltration of macrophages into adipose tissue [39–41].”
BackgroundXu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738 · cited 1×
“Importantly, inflammation must be considered as an intricate network of stimuli, humoral and cellular proinflammatory responses, counterregulatory mechanisms and active suppression of inflammation in the absence of stimuli that do not require a potent reaction [24].”
BackgroundBaggiolini, M., Dewald, B., & Moser, B. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.675 · Cited by 2,192 · cited 1×
“Chemokines represent a family of small molecular weight proteins which control leukocyte trafficking and activation and act as key mediators of inflammation and other patho-physiological states [37, 38].”
BackgroundDiabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"?
(1962) · PubMed Central · Cited by 2,182
Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes
Pickup, J. C. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.813 · Cited by 1,414 · cited 2×
“These studies described the association of type 2 diabetes and elevated levels of acute-phase proteins like C-reactive protein (CRP), cytokines like interleukin-6 (IL-6) and other markers of leukocyte or endothelial cell activation [9 and references therein, 10].”
BackgroundGerard, C., & Rollins, B. J. (2001) · Nature Immunology · doi:10.1038/84209 · Cited by 1,357 · cited 1×
“Chemokines represent a family of small molecular weight proteins which control leukocyte trafficking and activation and act as key mediators of inflammation and other patho-physiological states [37, 38].”
BackgroundPickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,242
Adiponectin and protection against type 2 diabetes mellitus
Spranger, J., Kroke, A., Möhlig, M., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12255-6 · Cited by 1,120 · cited 1×
“…a single marker has been described as yet which appears to be protective: The adipocyte-derived cytokine adiponectin combines insulin-sensitising and anti-inflammatory properties, and high levels of serum adiponectin are associated with significantly reduced risk of diabetes development [12, 13].”
BackgroundAdiponectin and development of type 2 diabetes in the Pima Indian population
Lindsay, R. S., Funahashi, T., Hanson, R. L., Matsuzawa, Y., Tanaka, S., Tataranni, P. A., Knowler, W. C., & Krakoff, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09335-2 · Cited by 1,094 · cited 1×
“…a single marker has been described as yet which appears to be protective: The adipocyte-derived cytokine adiponectin combines insulin-sensitising and anti-inflammatory properties, and high levels of serum adiponectin are associated with significantly reduced risk of diabetes development [12, 13].”
Cited by
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Dietary factors and low-grade inflammation in relation to overweight and obesity
Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jönsson, L. S., Kolb, H., Lansink, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511005460 · Cited by 1,098
“(5) There is a need for toxicological evaluation of wellcharacterised AGE in animal studies.”
InfluentialSelf-citationKORA - A Research Platform for Population Based Health Research
Holle, R., Happich, M., Löwel, H., & Wichmann, H. (2005) · Das Gesundheitswesen · doi:10.1055/s-2005-858235 · Cited by 754
Self-citationFirmann, M., Mayor, V., Vidal, P. M., Bochud, M., Pécoud, A., Hayoz, D., Paccaud, F., Preisig, M., Song, K. S., Yuan, X., et al. (2008) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-8-6 · Cited by 721
Akash, M. S. H., Rehman, K., & Liaqat, A. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26174 · Cited by 690
Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease
Pedersen, B. K. (2017) · European Journal of Clinical Investigation · doi:10.1111/eci.12781 · Cited by 617
Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and Inflammation
Singh, V., & Ubaid, S. (2020) · Inflammation · doi:10.1007/s10753-020-01242-9 · Cited by 427
KORA-gen - Resource for Population Genetics, Controls and a Broad Spectrum of Disease Phenotypes
Wichmann, H.-E., Gieger, C., & Illig, T. (2005) · Das Gesundheitswesen · doi:10.1055/s-2005-858226 · Cited by 417
Self-citationSlyepchenko, A., Maes, M., Jacka, F. N., Köhler, C. A., Barichello, T., McIntyre, R. S., Berk, M., Grande, I., Foster, J. A., Vieta, E., et al. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000448957 · Cited by 278
High glucose concentrations alter the biomineralization process in human osteoblastic cells
García-Hernández, A., Arzate, H., Gil-Chavarría, I., Rojo, R., & Moreno-Fierros, L. (2012) · Bone · doi:10.1016/j.bone.2011.10.032 · Cited by 193
Molecular links between Alzheimer’s disease and diabetes mellitus
Yang, Y., & Song, W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.009 · Cited by 201
Bray, J. J. H., Foster‐Davies, H., Salem, A., Hoole, A. L., Obaid, D. R., Halcox, J. P. J., & Stephens, J. W. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14399 · Cited by 194
The physiology of optimizing health with a focus on exercise as medicine
Pedersen, B. K. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114339 · Cited by 163
Yu, S., Cheng, Y., Zhang, L., Yin, Y., Xue, J., Li, B., Gong, Z., Gao, J., & Mu, Y. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1474-8 · Cited by 168
“These immunological changes include alterations in the levels of inflammatory cytokines and chemokines [9, 10], changes in the number of infiltrating leukocytes [11–13], and the development of tissue fibrosis [14, 15].”
Li, F., Feng, Y. Y., Chen, G., Qin, L., Chun-ling, F., & Chen, L. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.01.032 · Cited by 170
Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease
Donath, M. Y., Meier, D. T., & Böni-Schnetzler, M. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00002 · Cited by 124
Targeting the NLRP3 inflammasome–IL-1β pathway in type 2 diabetes and obesity
Meier, D. T., Souza, J. D. P., & Donath, M. Y. (2024) · Diabetologia · doi:10.1007/s00125-024-06306-1 · Cited by 133
Flynn, M. G., Markofski, M. M., & Carrillo, A. E. (2019) · Aging and disease · doi:10.14336/ad.2018.0326 · Cited by 111
Autophagy and oxidative stress in non-communicable diseases: A matter of the inflammatory state?
Peña‐Oyarzún, D., Bravo, R., Díaz‐Vegas, A., Aleman, L., Chiong, M., García, L., Claudia Bambs, S., Troncoso, R., Cifuentes, M., Morselli, E., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.084 · Cited by 114
Coenzyme Q10: Novel Formulations and Medical Trends
Pastor‐Maldonado, C. J., Suarez-Rivero, J. M., Povea-Cabello, S., Álvarez-Córdoba, M., Villalón-García, I., Munuera-Cabeza, M., Suárez-Carrillo, A., Talaverón-Rey, M., & Sánchez-Alcázar, J. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228432 · Cited by 84
Sakurai, T., Ogasawara, J., Shirato, K., Izawa, T., Oh‐ishi, S., Ishibashi, Y., Radak, Z. O., Ohno, H., & Kizaki, T. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9410954 · Cited by 76
“Moreover, the blood concentration of macrophage migration inhibitory factor (MIF), which is a humoral factor that controls the migration of macrophage, in type 2 diabetic patients has been reported to be higher than that of healthy persons [21].”
BackgroundDiet and Inflammation in Alzheimer’s Disease and Related Chronic Diseases: A Review
Gardener, S. L., Rainey‐Smith, S. R., & Martins, R. N. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150765 · Cited by 70
Otsuka, Y., Kiyohara, C., Kashiwado, Y., Sawabe, T., Nagano, S., Kimoto, Y., Ayano, M., Mitoma, H., Akahoshi, M., Arinobu, Y., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0196368 · Cited by 62
Häfner, S., Baumert, J. J., Emeny, R. T., Lacruz, M. E., Bidlingmaier, M., Reincke, M., Kuenzel, H., Holle, R., Rupprecht, R., & Ladwig, K. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.06.007 · Cited by 63
Self-citationMiele, E. M., & Headley, S. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0927-7 · Cited by 58
Murdolo, G., Nowotny, B., Celi, F., Donati, M., Bini, V., Papi, F., Gornitzka, G., Castellani, S., Roden, M., Falorni, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017264 · Cited by 53
“The rationale behind the selection of this specific panel of inflammatory molecules in our Luminex platform was that: 1) growing data underscore the role of chemokines as modulators of macrophage infiltration into adipose tissue and predictors of diabetes risk [1,33,34,35]; and, 2) no prior study evaluated sex differe…”
BackgroundSelf-citationMelo, L. C., Dativo-Medeiros, J., Menezes-Silva, C. E., Barbosa, F. T., Sousa-Rodrigues, C. F. D., & Rabelo, L. A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8523728 · Cited by 50
Aslani, Z., Qorbani, M., Hébert, J. R., Shivappa, N., Motlagh, M. E., Asayesh, H., Mahdavi‐Gorabi, A., & Kelishadi, R. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114518003240 · Cited by 54
Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD
Nobili, V., Alisi, A., Musso, G., Scorletti, E., Calder, P. C., & Byrne, C. D. (2016) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1092106 · Cited by 46
Zhang, C., Zhang, J., Liu, Z., & Zhou, Z. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3400-z · Cited by 55
Volpe, C. M. O., Abreu, L. F. M., Gomes, P. S., Gonzaga, R. M., Veloso, C. A., & Nogueira‐Machado, J. A. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/479587 · Cited by 52
Knudsen, S. H., & Pedersen, B. K. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0642-1 · Cited by 41
Mazloom, H., Alizadeh, S., Pasalar, P., Nasli‐Esfahani, E., & Meshkani, R. (2015) · Cytokine · doi:10.1016/j.cyto.2015.07.007 · Cited by 44
Schwab, S., Heier, M., Schneider, A. L. C., Fischer, B., Huth, C., Peters, A., & Thorand, B. (2013) · The journal of nutrition health & aging · doi:10.1007/s12603-013-0418-8 · Cited by 42
Self-citationComplement in metabolic disease: metaflammation and a two-edged sword
King, B. C., & Blom, A. M. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00873-w · Cited by 42
An Update of Anthraquinone Derivatives Emodin, Diacerein, and Catenarin in Diabetes
Martorell, M., Castro, N., Victoriano, M., Capó, X., Tejada, S., Vitalini, S., Pezzani, R., & Sureda, A. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/3313419 · Cited by 41
Telle‐Hansen, V. H., Christensen, J. J., Ulven, S. M., & Holven, K. B. (2017) · Genes & Nutrition · doi:10.1186/s12263-017-0580-4 · Cited by 41
“Conclusion Obesity is associated with pathological changes in adipose tissue morphology, including infiltration of immune cells, and obese individuals have higher circulating levels of inflammatory markers than lean individuals [5, 7].”
Alimohammadi, M., Rahimi, A. A. R., Faramarzi, F., Golpour, M., Jafari-Shakib, R., Alizadeh‐Navaei, R., & Rafiei, A. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00817-8 · Cited by 32
“On the other hand, inflammation plays a significant role in multiple illnesses, including cardiovascular disease (CVD), chronic kidney disease, type 2 diabetes, chronic obstructive pulmonary disease (COPD), and cancer (Coussens and Werb 2002; Han et al. 2015; Herder et al. 2005; Libby, 2006; Tudorache et al. 2015).”
BackgroundHäfner, S., Baumert, J., Emeny, R. T., Lacruz, M. E., Bidlingmaier, M., Reincke, M., & Ladwig, K. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.03.015 · Cited by 31
“Study design, sampling method and data collection have been described in detail elsewhere (Herder et al., 2005).”
Rathmann, W., Haastert, B., Icks, A., Herder, C., Kolb, H., Holle, R., Mielck, A., Meisinger, C., Wichmann, H. ‐., & Giani, G. (2005) · Das Gesundheitswesen · doi:10.1055/s-2005-858227 · Cited by 28
Self-citationÖztekin, Ö. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.01.054 · Cited by 31
“Type 2 DM is associated with a chronic low-grade systemic inflammation [10].”
BackgroundDo proinflammatory cytokines play a role in clozapine-associated glycometabolism disorders?
Zhao, T., Zhang, K., Zhang, Y., Yang, Y., Ning, X., Hu, Y. X., Li, X., Zhang, Y., Xia, L., Ren, Z., et al. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05824-9 · Cited by 24
“…important part of the early inflammatory response to diabetes (Donath et al. 2019), and clinical research has found that the circulating levels of acute-phase proteins, cytokines, and chemokines in type 2 diabetes patients are elevated (Herder et al. 2005; Van Dyke et al. 2017; Volpe et al. 2014).”
BackgroundKing, B. C., & Blom, A. M. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.12.009 · Cited by 27
Podolefsky, N. S., Moore, E. B., & Perkins, K. K. (2013) · arXiv (Cornell University) · doi:10.48550/arxiv.1306.6544 · Cited by 31
Mao, J., Ai, J., Zhou, X., Shenwu, M., Ong, M., Blue, M., Washington, J. T., Wang, X., & Deng, Y. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-s5-s12 · Cited by 23
“In addition, obesity and immune/inflammatory processes contribute to the onset of T2D [6-9].”
BackgroundWang, J., Yu, Z., Tao, Y., Liu, Y., Wang, Y., Guo, Q., Xue, J., Wen, X., Zhang, Q., Xu, X., et al. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13573 · Cited by 23
Cost-effectiveness of type 2 diabetes screening: results from recently published studies
Icks, A., Rathmann, W., Haastert, B., John, J., Löwel, H., Holle, R., & Giani, G. (2005) · Das Gesundheitswesen · doi:10.1055/s-2005-858232 · Cited by 22
Self-citationLiu, C., Lu, L., Kong, Q., Li, Y., Wu, H., Yang, W. E., Shan-dan, X., Yang, X., Song, X., Yang, J. Y., et al. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-s17-s5 · Cited by 22
Zhang, L., Qin, Y., Liang, D., Li, L., Liang, Y., Chen, L., Tong, L., Zhou, J., Li, H., & Zhang, H. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-017-0644-x · Cited by 22
Novel Biomarkers of Inflammation for the Management of Diabetes: Immunoglobulin-Free Light Chains
Matsumori, A. (2022) · Biomedicines · doi:10.3390/biomedicines10030666 · Cited by 23
IL-6 promoter polymorphisms and quantitative traits related to the metabolic syndrome in KORA S4
Grallert, H., Huth, C., Kolz, M., Meisinger, C., Herder, C., Straßburger, K., Giani, G., Wichmann, H. ‐., Adamski, J., Illig, T., et al. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.05.002 · Cited by 22
Self-citationThe Rationale for Insulin Therapy in Alzheimer’s Disease
Ribarič, S. (2016) · Molecules · doi:10.3390/molecules21060689 · Cited by 22
Roshanzamir, N., & Hassan‐Zadeh, V. (2019) · Immunological Investigations · doi:10.1080/08820139.2019.1656227 · Cited by 21
“In type 2 diabetic patients, the levels of circulating cytokines, chemokines and acute phase proteins are markedly increased (Herder et al., 2009, 2005; Pickup et al., 1997; Spranger et al., 2003) and high levels of interleukin 1β (IL-1β) along with interleukin-6 (IL-6) could be used as a predictor…”
BackgroundHyperglycaemia and the risk of post-surgical adhesion
Ferns, G. A., Hassanian, S. M., & Arjmand, M. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1776330 · Cited by 17
“Some studies have shown that acute phase reactants like C-reaction protein (CRP), fibrinogen, PAI, and serum amyloid A are secreted at a high level in chronic hyperglycaemia and DM (Pickup et al. 1997, Herder et al. 2005, Lin et al. 2005).”
BackgroundDiabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
Infante, M., Padilla, N., Alejandro, R., Caprio, M., Della‐Morte, D., Fabbri, A., & Ricordi, C. (2022) · Medicina · doi:10.3390/medicina58050571 · Cited by 19
Hepprich, M., Mudry, J. M., Gregoriano, C., Jornayvaz, F. R., Carballo, S., Wojtusciszyn, A., Bart, P., Chiche, J., Fischli, S., Baumgartner, T., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101649 · Cited by 18
Mikkelsen, R. R., Hundahl, M. P., Torp, C. K., Rodríguez‐Carrio, J., Kjølby, M., Bruun, J. M., & Kragstrup, T. W. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174998 · Cited by 16
Health Inequalities among Persons with Type 2 Diabetes: The Example of Intermittent Claudication
Mielck, A., Reisig, V., & Rathmann, W. (2005) · Das Gesundheitswesen · doi:10.1055/s-2005-858230 · Cited by 15
Self-citationDisease-Management-Programme in Deutschland: Erste Reaktionen der Diabetiker
Eller, M., Satzinger, W., Holle, R., Meisinger, C., & Thorand, B. (2005) · Das Gesundheitswesen · doi:10.1055/s-2005-858255 · Cited by 14
Self-citationMohamadi, A., Shiraseb, F., Mirzababaei, A., Hosseininasab, D., Rasaei, N., Clark, C. C. T., & Mirzaei, K. (2022) · International Journal of Clinical Practice · doi:10.1155/2022/8099382 · Cited by 16
“normal-weight persons [56, 57]; indeed, the elevated abdominal fat mass is related to a chronic increase of the circulating concentrations of inflammatory mediators containing multiple acute-phase inflammatory proteins including CRP [58, 59].”
High Plasma Pentraxin 3 Levels in Diabetic Polyneuropathy Patients with Nociceptive Pain
Şalçini, C., Atasever-Arslan, B., Sunter, G., Gür, H., Işık, F. B., Saylan, C. C., & Yalçın, A. D. (2016) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.239.73 · Cited by 12
Ubaid, S., Rumman, M., Singh, B., Akhtar, M. S., Mahdi, A. A., & Pandey, S. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00639 · Cited by 11
Dyke, A. L. V., Kuhs, K. A. L., Shiels, M. S., Koshiol, J. E., Trabert, B. L., Loftfield, E., Purdue, M. P., Wentzensen, N., Pfeiffer, R. M., Katki, H. A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182359 · Cited by 10
Nokkaew, N., Mongkolpathumrat, P., Junsiri, R., Jindaluang, S., Tualamun, N., Manphatthanakan, N., Saleesee, N., Intasang, M., Sanit, J., Adulyaritthikul, P., et al. (2019) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-019-0815-9 · Cited by 11
Determinants of Cardiovascular Risk in Diabetes Beyond Hyperglycemia
Badimón, L., Vera, R. H., & Vilahur, G. (2013) · Cited by 10
Lazarov, O., Minshall, R. D., & Bonini, M. G. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.020 · Cited by 11
Rakel, D. P., & Rindfleisch, J. A. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-2954-0.50092-2 · Cited by 9
Obesity in Humans and Dogs: Similarities, Links, and Differences
Tvarijonaviciute, A., Muñoz-Prieto, A., & Martínez-Subiela, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-30734-9_8 · Cited by 8
Metaflammation, NLRP3 Inflammasome Obesity and Metabolic Disease
Meiliana, A., & Wijaya, A. (2011) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v3i3.148 · Cited by 8
Stem cells as a regenerative medicine approach in treatment of microvascular diabetic complications
Poojari, A. S., Wairkar, S., & Kulkarni, Y. A. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102225 · Cited by 7
Epidemiology in Germany—general development and personal experience
Wichmann, H. ‐. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0290-7 · Cited by 7
Self-citationKohatsu, W., & Karpowicz, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00088-8 · Cited by 7
Okuda, M., Taguchi, Y., Takahashi, S., Tanaka, A., & Umeda, M. (2015) · Journal of Hard Tissue Biology · doi:10.2485/jhtb.24.77 · Cited by 5
Hillman, M., & Landin‐Olsson, M. (2011) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2011.14013 · Cited by 4
Akujuru, E. E., Aprioku, J. S., & Okerengwo, A. (2020) · Comparative Clinical Pathology · doi:10.1007/s00580-019-03086-8 · Cited by 6
Molecular Pathogenesis of Inflammatory Cytokines in Insulin Resistance Diabetes Mellitus
Bashir, H., Bhat, M. H., & Majid, S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100971 · Cited by 9
elaaty, T. A., Ismail, A. A., Meheissen, M. A., & Essawy, N. R. E. (2019) · Clinical Diabetology · doi:10.5603/dk.2019.0014 · Cited by 3
Lanka, N., Acharya, P., Virani, S., Afreen, S., Perthiani, A., Sangster, E., & Franchini, A. P. A. (2024) · Cureus · doi:10.7759/cureus.67065 · Cited by 5
“Additionally, it has been found that acute-phase reactants such as high-sensitivity CRP (hsCRP) and pro-inflammatory cytokines like IL-1 β and IL-6 are increased in T2DM [7].”
BackgroundType 2 Diabetes Mellitus as a Risk Factor for Alzheimer’s Disease
Bonds, J. A., Hart, P. C., Minshall, R. D., Lazarov, O., Haus, J. M., & Bonini, M. G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802851-3.00013-9 · Cited by 4
Donath, M. Y. (2021) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2021.07.010 · Cited by 5
Clinical Trials and Outcomes in Anti-inflammatory Therapies
Shukla, S. P., Kumar, V., Singh, S., Dwivedi, A., & Tripathi, A. (2024) · Springer eBooks · doi:10.1007/978-981-97-0157-5_12 · Cited by 2
Shaikh, S. A. A., Denny, C., Natarajan, S., Nandita, K. P., Nayak, S. U., & Sujir, N. (2024) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-024-01427-0 · Cited by 2
“Reports have shown that, in comparison to normal con-trol, the levels of these previously stated pro-inflammatory cytokines, also referred to as mediators, have become abnormally high in insulin-resistant and T2DM experimental animal models and/or patients [21–25].”
Kohatsu, W. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00070-4 · Cited by 1
Dorsemans, A.-C. (2018) · theses.fr (ABES) · doi:10.70675/5837f59fz9b16z4f74z8152z29531da792b6 · Cited by 2
Pham, R. N., & Do, T. M. N. (2011) · Univ. Duesseldorf: Duesseldorfer Dokumenten- und Publikationsserver
Rakel, D. P., & Rindfleisch, J. A. (2009) · Elsevier eBooks · doi:10.1016/b978-84-458-1911-1.50088-9 · Cited by 1
Gesamtverzeichnis der Publikationen aus MONICA/KORA Augsburg 1984 bis Anfang 2005
KORA-Studiengruppe, M., & ] (2005) · Das Gesundheitswesen · doi:10.1055/s-2005-858402
The effects of short-term low-carbohydrate and ketogenic interventions on cardiometabolic health
Myette‐Côté, É. (2019) · cIRcle (University of British Columbia) · doi:10.14288/1.0378478
“Cross-sectional and prospective studies previously concluded that T2D and obesity are low-grade systemic inflammatory states as shown by elevated levels of acute-phase proteins, cytokines and chemokines [114-116].”
BackgroundRELATIONSHIP BETWEEN LEUKOCYTE COUNT, ERYTHROCYTE SEDIMENTATION RATE, AND TYPE 2 DIABETES MELLITUS
Afan, A. M., Zendah, M. E., Saida, H., & Alabdeli, S. S. (2010) · Biochemistry Letters · doi:10.21608/blj.2010.64442
Calder, P. C. (2025) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2025.03.018
Nemati, M., Nemati, F., Hosseinzadeh, Z., & Ghaffari, M. K. (2025) · doi:10.31038/edmj.2025932
From the laboratory to the clinic: advancing helminthic therapy for type 2 diabetes
Zhu, Y., Fei, X., Wang, R., Wang, J., Liu, M., Zhang, Y., Li, X., Xu, J., Zhao, Q., Zhang, X., et al. (2025) · Journal of Helminthology · doi:10.1017/s0022149x25100576
“Further analysis revealed that deworming led to significant reductions in pro-inflammatory cytokines-IL-1 α , IL-1 β , IL-6, IL-12, IL-18, IL-23, IL-27, G-CSF, and GM-CSF and chemokines-CCL1, CCL2, CCL3, CCL11, CXCL1, CXCL2, CXCL8, CXCL9, CXCL10, and CXCL11.”
Diabetes tipo II e resolvinas D1
da Silva, I. A. M. B. (2015) · Repositório Comum (Repositório Científico de Acesso Aberto de Portugal)
Andrusiów, S., Dratwa, M., Łacina, P., Bochen, P., Gładysz, K., Szponar, B., Koszewicz, M. A., & Bogunia‐Kubik, K. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1738817
Vasudevan, D. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i3.113843
Caradu, C. (2020) · theses.fr (ABES) · doi:10.70675/7e30d752z9f28z4e3cz859ezdf2097118a58 · Cited by 1
The association between infant gut microbiota and low-grade inflammation later in childhood
Juvonen, I. (2024) · UEF eRepo (University of Eastern Finland)
Metadata
- Authors
- Herder, C., Illig, T., Rathmann, W., Martin, S., Haastert, B., Müller-Scholze, S., Holle, R., Thorand, B., Koenig, W., Wichmann, H., & Kolb, H.
- Affiliations
- Deutsches Diabetes-Zentrum e.V. (DE)
- Helmholtz Munich (DE)
- Venue
- Das Gesundheitswesen
- Publisher
- Georg Thieme Verlag KG
- Published
- 2005-07-20
- Volume
- 67
- Issue
- S 01
- Pages
- 115-121
- ISSN
- 0941-3790 (ISSN-L)
- 1439-4421
- OpenAlex
- W2074266524
- Cited by
- 97
- References
- 42
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 1 · 2022: 6 · 2021: 8 · 2020: 7 · 2019: 7 · 2018: 7 · 2017: 10 · 2016: 5 · 2015: 5 · 2014: 3 · 2013: 5 · 2012: 1
- FWCI
- 2.61
- Type
- journal article
- Language
- de
- Open access
- bronze
- doi.org
- Locations
- Das Gesundheitswesen (publishedVersion)
- PubMed (publishedVersion)
- Site cant be reached (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, low-grade inflammation, acute phase proteins, C-reactive protein, interleukin-6, TNF-α, impaired glucose tolerance, insulin resistance, innate immunity, cytokines, diabetes pathogenesis, obesity
- MeSH terms
- Acute-Phase Proteins, Adult, Aged, Diabetes Mellitus, Type 2, Female, Germany, Humans, Inflammation, Male, Middle Aged, Population Surveillance, Registries, Research Design, Risk Factors, Cohort Studies, Biomarkers, Comorbidity, Incidence, Survival Analysis, Case-Control Studies, Cytokines, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.